BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18519410)

  • 1. Non-MALT marginal zone lymphomas.
    Thieblemont C
    Ann Oncol; 2008 Jun; 19 Suppl 4():iv70-3. PubMed ID: 18519410
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
    Thieblemont C; Felman P; Berger F; Dumontet C; Arnaud P; Hequet O; Arcache J; Callet-Bauchu E; Salles G; Coiffier B
    Clin Lymphoma; 2002 Jun; 3(1):41-7. PubMed ID: 12141954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Zucca E; Dreyling M;
    Ann Oncol; 2010 May; 21 Suppl 5():v175-6. PubMed ID: 20555074
    [No Abstract]   [Full Text] [Related]  

  • 5. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL.
    Kahl B; Yang D
    Hematology Am Soc Hematol Educ Program; 2008; ():359-64. PubMed ID: 19074110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Marginal zone lymphomas: extranodal MALT type, nodal and splenic].
    Dallenbach FE; Coupland SE; Stein H
    Pathologe; 2000 Mar; 21(2):162-77. PubMed ID: 10840821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Splenic marginal zone lymphoma].
    Dimopoulos K; Pedersen M
    Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    Elmahy H; Hawley I; Beard J
    Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-tailored treatment of splenic marginal zone lymphoma.
    Castelli R; Balzarotti M; Salvi E; Simona Rossi R; Lambertenghi Deliliers G; Bergamaschini L; Gidaro A
    Anticancer Drugs; 2022 Jan; 33(1):e36-e42. PubMed ID: 34407041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-MALT marginal zone lymphoma.
    Thieblemont C; Davi F; Noguera ME; Brière J
    Curr Opin Hematol; 2011 Jul; 18(4):273-9. PubMed ID: 21577105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ; Ali S
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.
    Kalpadakis C; Pangalis GA; Sachanas S; Rontogianni D; Korkolopoulou P; Milionis V; Vassilakopoulos TP; Papadaki HA; Angelopoulou MK
    Leuk Lymphoma; 2016 Nov; 57(11):2705-8. PubMed ID: 27082039
    [No Abstract]   [Full Text] [Related]  

  • 13. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone.
    de Wolf-Peeters C; Pittaluga S; Dierlamm J; Wlodarska I; Van Den Berghe H
    Leuk Lymphoma; 1997 Aug; 26(5-6):467-78. PubMed ID: 9389354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
    Bennett M; Schechter GP
    Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic marginal zone lymphoma in 5 dogs (2001-2008).
    Stefanello D; Valenti P; Zini E; Comazzi S; Gelain ME; Roccabianca P; Avallone G; Caniatti M; Marconato L
    J Vet Intern Med; 2011; 25(1):90-3. PubMed ID: 21092007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine analogs in marginal-zone lymphomas.
    Horning SJ
    Ann Oncol; 1996; 7 Suppl 6():S21-6. PubMed ID: 9010575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biological diversity of splenic marginal zone lymphoma.
    Matutes E
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1185-9. PubMed ID: 19761421
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical presentation and management of marginal zone lymphomas.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
    Lenglet J; Traullé C; Mounier N; Benet C; Munoz-Bongrand N; Amorin S; Noguera ME; Traverse-Glehen A; Ffrench M; Baseggio L; Felman P; Callet-Bauchu E; Brice P; Berger F; Salles G; Brière J; Coiffier B; Thieblemont C
    Leuk Lymphoma; 2014 Aug; 55(8):1854-60. PubMed ID: 24206091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.
    Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Kontopidou FN; Yiakoumis X; Kokoris SI; Dimitriadou EM; Dimopoulou MN; Moschogiannis M; Korkolopoulou P; Kyrtsonis MC; Siakantaris MP; Papadaki T; Tsaftaridis P; Plata E; Papadaki HE; Vassilakopoulos TP
    Oncologist; 2013; 18(2):190-7. PubMed ID: 23345547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.